Scientists develop multifunctional brain implant for precise neural research
Needle-thin device combines drug delivery, electrical recording, and light stimulation in one implant.
1Multifunctional neural research tool
Researchers from DTU, University of Copenhagen, and University College London have developed a needle-thin brain electrode called microfluidic Axialtrode (mAxialtrode). Unlike conventional implants that perform single functions, this device integrates microscopic channels for drug delivery, electrical recording, and light stimulation along its length. The innovation allows simultaneous interaction with multiple brain regions, enabling more comprehensive studies of neural circuits involved in epilepsy, memory, and decision-making processes.
2Soft material advantage
The mAxialtrode uses soft, plastic-like optical fibers instead of traditional rigid silicon materials that often cause tissue irritation. Its specially angled tip and flexibility allow it to move with brain tissue rather than pressing against it, reducing inflammatory responses. This design improvement addresses a major limitation of current implants that can trigger adverse reactions when remaining in the brain for extended periods. The finished fiber measures less than 0.5mm across while maintaining structural integrity.
3Precision drug delivery system
The implant features eight microscopic channels surrounding a light-conducting core, capable of transporting liquids to specific brain regions. Researchers demonstrated the ability to inject different substances at separate depths with delivery points spaced nearly 3mm apart. This precision targeting could eventually enable localized treatment of neurological conditions while minimizing systemic side effects. The channels can also accommodate ultra-thin metal wires for electrical activity measurement.
4Dual-light stimulation capability
In vivo tests with mice showed the device can stimulate nerve cells using both blue and red light wavelengths simultaneously. This optogenetic functionality allows researchers to activate specific neural populations while monitoring activity across different brain layers. The system successfully recorded electrical signals from both superficial (cerebral cortex) and deeper structures (hippocampus), providing multidimensional data about neural communication pathways.
5Current research applications
While therapeutic use remains years away, the mAxialtrode offers immediate value as a research tool. Its multi-point interaction capability helps scientists study how signals propagate through different brain layers during complex processes. The device's lightweight design (tested in moving mice without discomfort) enables longer observation periods than conventional implants. Current studies focus on neural circuit analysis relevant to epilepsy models.
6Technical development process
The implant begins as a large polymer rod that researchers heat and draw into an extremely thin fiber with sub-millimeter precision. This manufacturing technique creates a structure with a light-conducting core surrounded by functional microchannels. The team has conducted both laboratory and in vivo validation, collaborating with experts in neural circuit analysis from multiple institutions to test the system's capabilities.
7Regulatory pathway ahead
Postdoc Kunyang Sui emphasizes the technology requires extensive testing and regulatory approvals before clinical use. The research team is pursuing patents while determining requirements for human trials. Current focus remains on refining the device's research applications, particularly for studying communication between different brain layers that underlie many neurological functions and disorders.
8Future therapeutic potential
Long-term applications could include combined drug delivery and electrical/light stimulation for neurological treatments. The ability to precisely target specific brain regions while monitoring effects in real-time offers advantages over existing therapies. However, researchers caution that transitioning from animal models to human patients presents significant technical and biological challenges that must be addressed through continued development.